Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis

PURPOSE: This study aimed to assess the diagnostic performance of circulating tumor DNA (ctDNA) in hepatocellular carcinoma (HCC). MATERIALS AND METHODS: We enrolled all relevant studies published up to 5 January 2022. Three primary subgroups were investigated: qualitative or quantitative ctDNA anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jia Jie, Lv, Yanqing, Ji, Huifan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637356/
https://www.ncbi.nlm.nih.gov/pubmed/36348665
http://dx.doi.org/10.7717/peerj.14303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637356/
https://www.ncbi.nlm.nih.gov/pubmed/36348665
http://dx.doi.org/10.7717/peerj.14303

Ejemplares similares